Company Resources
Ultimate Guide to Raising Capital
- Published June 15, 2022 1:38AM UTC
- Publisher codingheads
- Categories Venture Investor Interviews
Transforming your company from unknown to known
Get insights into the murky waters of raising capital in Wholesale Investor’s FREE ultimate guide where we take a deep dive alongside experts breaking the myths surrounding the enigmatic process of startup funding.
What you’ll learn:
- Where to find investors, from ground zero (with videos from those who’ve done it)
- The different stages of startup financing
- Creating an effective pitch deck (with a full deck template inside)
- How to take an investor from interested to committed
- Valuing team effort
- Exit Options & Strategies
…and much more!
Download the guide now:
Venture Investor Interviews
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
